Jeremy Chang, M.D.
NPI 1699206839 · Hematology & Oncology Physician · San Diego, CA
Enrolled with Medicare as Practitioner - Hematology/Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Jeremy Chang, M.D. is a Hematology & Oncology Physician provider in San Diego, CA (NPI 1699206839).
Provider details
- NPI number
- 1699206839
- Entity type
- Individual
- Primary specialty
- Hematology & Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- A157858 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
9 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
2 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
605 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 152 | $17 |
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 142 | $192 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 142 | $17 |
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 134 | $148 |
| New Patient Office Or Other Outpatient Visit With a High Level of Medical Decision Making, If Using Time, 60 Minutes Or More99205 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Prochlorperazine Maleate | 51 | 28 |
| Ondansetron Hcl | 37 | 22 |
| Olanzapine | 31 | 21 |
| Loperamide Hclbrand: Loperamide | 28 | 17 |
| Mirtazapine | 14 | — |
| Trazodone Hcl | 11 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$43 across 2 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (1)
- 2020 Zonal Ave Ste Ird620Los Angeles, CA 90089-9520Phone: (323) 226-7593
Registry dates
- Enumerated
- 2017-03-21
- Last updated
- 2025-11-12
- Certified
- 2025-11-12
Frequently asked questions
- What is Jeremy Chang's NPI number?
- Jeremy Chang's National Provider Identifier (NPI) is 1699206839, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Jeremy Chang's specialty?
- Jeremy Chang is listed in the NPPES registry with a primary specialty of Hematology & Oncology Physician (Allopathic & Osteopathic Physicians).
- Where is Jeremy Chang located?
- Jeremy Chang's practice location on file with NPPES is 200 W Arbor Dr, San Diego, CA 92103-9000.
- What is Jeremy Chang's phone number?
- The practice phone number listed in the NPPES registry for Jeremy Chang is (800) 926-8273.
- Does Jeremy Chang accept Medicare?
- Jeremy Chang is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Jeremy Chang's NPI active?
- Yes — Jeremy Chang's NPI (1699206839) is active in the NPPES registry as of the last update on 2025-11-12.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.